Avery Dennison white paper on Falsified Medicines Directive

The EU Directive on Falsified Medicines (Directive 2011/62/EU) was published in July 2011. It reflects an increasingly complex distribution network for medicinal products, with many different players – and a pressing need to ensure reliability across the entire supply chain.
Harmonized safety features across the entire EU are on their way. Legislation will be in force by the end of 2015, and manufacturers and other stakeholders will then have three years to decide on and implement a range of different safety features. It means new responsibilities for wholesalers and brokers, including logos for legally operating online pharmacies (Labels & Labelling, 4 August 2015).
Click here to download the white paper (764 kB).
Click here for more information about the NVC E-Course Pharmaceutical Packaging.
Click here for information about the pharmaceutical packaging exhibition InnoPack 2015 (Madrid, 13-15 October).

If you have any questions about this subject, please contact us: info@nvc.nl, +31-(0)182-512411. This item is also included in our monthly overview, the NVC Members-only Update.